Stable amorphous amifostine compositions and methods for the preparation and use of same

Details for Australian Patent Application No. 2004203350 (hide)

Owner MedImmune Oncology, Inc.

Inventors Zadei, Javad M; Stogniew, Martin

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004203350

Parent 17255

Filing date 22 July 2004

Wipo publication date 19 August 2004

Acceptance publication date 23 March 2006

International Classifications

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 31/66 (2006.01) - Phosphorus compounds

Event Publications

5 August 2004 Complete Application Filed

19 August 2004 Application Open to Public Inspection

  Published as AU-B-2004203350

23 March 2006 Application Accepted

  Published as AU-B-2004203350

20 July 2006 Standard Patent Sealed

25 September 2008 Alteration of Name

  The name of the patentee has been altered to MedImmune, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004203351-In-situ Thermal Processing of a Coal Formation Leaving One or More Selected Unprocessed Areas

2004203349-Scalpel blade exchange apparatus and method